Compare SEV & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEV | CPIX |
|---|---|---|
| Founded | 2019 | 1999 |
| Country | United States | United States |
| Employees | 46 | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.9M | 92.3M |
| IPO Year | N/A | 2007 |
| Metric | SEV | CPIX |
|---|---|---|
| Price | $1.89 | $7.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 271.8K | 64.0K |
| Earning Date | 05-16-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 58.70 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17,757.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $1.29 | $1.85 |
| 52 Week High | $11.24 | $7.36 |
| Indicator | SEV | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 36.41 | 69.82 |
| Support Level | $1.29 | $5.42 |
| Resistance Level | $2.45 | N/A |
| Average True Range (ATR) | 0.15 | 0.62 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 17.57 | 94.63 |
Aptera Motors Corp engages in the development, production, and distribution of energy efficient solar-powered, battery-electric vehicles. The company has designed the Aptera vehicle to provide up to an estimated 40 miles per day by collecting energy from the sun and storing it in its proprietary battery pack. The company operates as a single reportable segment focused on the development of solar electric vehicles.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.